A NEW treatment for locally
advanced basal cell carcinoma
(laBCC) called Odomzo (sonidegib)
from Novartis has been approved
by the US Food and Drug
Administration.The above snippet is the first part of an article sent to subscribers in Pharmacy Daily's issue from 28 Jul 15 To see the full story, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 28 Jul 15
A PHARMACIST facing charges of sexual assaulting a patient will be allowed to practice after an NSW Civil and Administrative Tribunal overturned a suspension handed down by the Pharmacy Council of NSW in Aug.